VeriMomБезопасен ли ginsenoside rh4 при беременности?
No harmonised CLP classification, no SCCS or CIR cosmetic safety assessment specific to ginsenoside Rh4 was found and there are no published reproductive/teratology studies for Rh4; therefore hazard is default 0. However, some ginsenosides show estrogen-related or bioactive signaling effects in vitro and Rh4 shows biological activity in cultured cells and animal models (e.g. anti‑tumor, AMPK, gut/liver signaling), so a theoretical mechanistic concern (structural/class similarity to other ginsenosides) is noted (m=1). Topical cosmetic exposure is expected to give negligible systemic absorption for a large polar triterpenoid glycoside, so exposure is scored e=0 for pregnant adults. Sources: PubMed studies on Rh4 activity, ECHA substance info (no harmonised CLP), EWG ingredient entry.
Related ingredients
Frequently asked questions
- Безопасен ли ginsenoside rh4 при беременности?
- No harmonised CLP classification, no SCCS or CIR cosmetic safety assessment specific to ginsenoside Rh4 was found and there are no published reproductive/teratology studies for Rh4; therefore hazard is default 0. However, some ginsenosides show estrogen-related or bioactive signaling effects in vitro and Rh4 shows biological activity in cultured cells and animal models (e.g. anti‑tumor, AMPK, gut/liver signaling), so a theoretical mechanistic concern (structural/class similarity to other ginsenosides) is noted (m=1). Topical cosmetic exposure is expected to give negligible systemic absorption for a large polar triterpenoid glycoside, so exposure is scored e=0 for pregnant adults. Sources: PubMed studies on Rh4 activity, ECHA substance info (no harmonised CLP), EWG ingredient entry.
- Безопасен ли ginsenoside rh4 при грудном вскармливании?
- No data showing Rh4 transfers in breastmilk or causes reproductive/lactation toxicity; no regulatory flags (harmonised CLP / SCCS / CIR). Theoretical mechanistic concern retained (m=1) because ginsenosides as a class have bioactivity in vitro and some other ginsenosides have shown estrogen receptor interactions in studies. Expected topical exposure and transfer to milk is low → e=0 for topical use. Relevant data on whole‑ginseng in LactMed highlights general ginseng concerns but does not provide Rh4‑specific breastfeeding data.
- Безопасен ли ginsenoside rh4 для кожи малыша?
- No infant‑specific reproductive or developmental toxicity data for Rh4 and no regulatory reproductive classification were identified, so hazard remains 0. Mechanistic score not increased because there is no infant‑specific mechanistic evidence. Exposure for baby skin is increased by +1 from adult (adult e=0 → baby e=1) because infant skin has higher permeability and surface‑area‑to‑weight; Rh4 is not demonstrated to be non‑absorbable. No data were found showing topical Rh4 causes adverse effects in infants 0–3 y.
- Как VeriMom оценивает ginsenoside rh4?
- VeriMom оценивает ginsenoside rh4 в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы ginsenoside rh4 при беременности?
- См. наш список безопасных альтернатив ginsenoside rh4 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.